Table 4 Participation rates across experimental condition (stratified by baseline depressed status)
1st call (N = 83/94) | 2nd call (N = 64/79) | |||||||
|---|---|---|---|---|---|---|---|---|
Experimental condition | Overall sample (N) | No symptomsa mean CESD (N = 62) | Symptoms mean CESD (N = 45) | No symptoms completed | Symptoms completed | No symptoms completed | Symptoms completed | Overall completion |
1 | 7 | 7.0 | 29.0 | n/ab | n/a | n/a | n/a | n/a |
2 | 7 | 6.0 | 29.7 | 4/4 (100%) | 3/3 (100%) | 4/4 (100%) | 2/3 (67%) | 13/14 (93%) |
3 | 7 | 3.0 | 31.0 | 5/5 (100%) | 2/2 (100%) | 4/5 (80%) | 2/2 (100%) | 13/14 (93%) |
4 | 6 | 2.5 | 26.0 | 1/3 (33%) | 2/3 (67%) | 3/3 (100%) | 1/3 (33%) | 7/12 (58%) |
5 | 6 | 8.2 | 16.0 | 5/5 (100%) | 1/1 (100%) | 5/5 (100%) | 1/1 (100%) | 12/12 (100%) |
6 | 6 | 7.7 | 36.0 | 2/3 (67%) | 3/3 (100%) | 2/3 (67%) | 3/3 (100%) | 10/12 (83%) |
7 | 7 | 3.7 | 23.3 | 1/3 (33%) | 4/4 (100%) | n/a | n/a | 5/7 (71%) |
8 | 6 | 5.3 | 19.5 | 3/3 (100%) | 3/3 (100%) | 3/3 (100%) | 2/3 (67%) | 11/12 (92%) |
9 | 7 | 8.7 | 23.7 | 4/4 (100%) | 3/3 (100%) | 3/4 (75%) | 3/3 (100%) | 13/14 (93%) |
10 | 7 | 8.3 | 27.8 | 3/3 (100%) | 4/4 (100%) | 3/3 (100%) | 4/4 (100%) | 14/14 (100%) |
11 | 7 | 7.8 | 21.5 | 4/5 (80%) | 2/2 (100%) | n/a | n/a | 6/7 (86%) |
12 | 7 | 8.7 | 29.3 | 2/3 (67%) | 3/4 (75%) | 2/3 (67%) | 2/4 (50%) | 9/14 (64%) |
13 | 7 | 7.2 | 27.0 | 4/5 (80%) | 2/2 (100%) | n/a | n/a | 6/7 (86%) |
14 | 6 | 5.0 | 38.5 | n/a | n/a | 3/4 (75%) | 1/2 (50%) | 4/6 (67%) |
15 | 7 | 6.8 | 22.0 | 5/5 (100%) | 1/2 (50%) | 4/5 (80%) | 1/2 (50%) | 11/14 (78%) |
16 | 7 | 9.5 | 29.3 | 4/4 (100%) | 3/3 (100%) | 4/4 (100%) | 2/3 (67%) | 13/14 (93%) |
Total | N = 107 | 6.7 (3.6) | 28.4 (11.2) | 47/55 (85%) | 36/39 (92%) | 40/46 (87%) | 24/33 (73%) | 147/173 (85%) |